2022
Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study
KOVARNIK, Tomas, Matsuo HITOSHI, Ales KRAL, Stepan JERABEK, David ZEMANEK et. al.Základní údaje
Originální název
Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study
Autoři
KOVARNIK, Tomas (203 Česká republika, garant), Matsuo HITOSHI, Ales KRAL (203 Česká republika), Stepan JERABEK (203 Česká republika), David ZEMANEK (203 Česká republika), Yoshiaki KAWASE, Hiroyuki OMORI, Toru TANIGAKI, Jan PUDIL (203 Česká republika), Alexandra VODZINSKA (203 Česká republika), Marian BRANNY (203 Česká republika), Roman ŠTÍPAL (203 Česká republika, domácí), Petr KALA (203 Česká republika, domácí), Jan MROZEK (203 Česká republika), Martin PORZER (203 Česká republika), Tomas GREZL (203 Česká republika), Kamil NOVOBILSKY (203 Česká republika), Oscar MENDIZ (203 Česká republika), Karel KOPRIVA (203 Česká republika), Martin MATES (203 Česká republika), Martin CHVAL (203 Česká republika), Zhi CHEN, Pavel MARTASEK (203 Česká republika) a Ales LINHART (203 Česká republika)
Vydání
Journal of the American Heart Association, Hoboken, Wiley-Blackwell, 2022, 2047-9980
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.400
Kód RIV
RIV/00216224:14110/22:00129589
Organizační jednotka
Lékařská fakulta
UT WoS
000789861900023
Klíčová slova anglicky
coronary flow reserve; fractional flow reserve; instantaneous wave-free ratio
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2023 10:45, Mgr. Tereza Miškechová
Anotace
V originále
Background:The FiGARO (FFR versus iFR in Assessment of Hemodynamic Lesion Significance, and an Explanation of Their Discrepancies) trial is a prospective registry searching for predictors of fractional flow reserve/instantaneous wave-free ratio (FFR/iFR) discrepancy. Methods and Results:FFR/iFR were analyzed using a Verrata wire, and coronary flow reserve was analyzed using a Combomap machine (both Philips-Volcano). The risk polymorphisms for endothelial nitric oxide synthase and for heme oxygenase-1 were analyzed. In total, 1884 FFR/iFR measurements from 1564 patients were included. The FFR/iFR discrepancy occurred in 393 measurements (20.9%): FFRp (positive)/iFRn (negative) type (264 lesions, 14.0%) and FFRn/iFRp (129 lesions, 6.8%) type. Coronary flow reserve was measured in 343 lesions, correlating better with iFR (R=0.56, P<0.0001) than FFR (R=0.36, P<0.0001). The coronary flow reserve value in FFRp/iFRn lesions (2.24 +/- 0.7) was significantly higher compared with both FFRp/iFRp (1.39 +/- 0.36), and FFRn/iFRn lesions (1.8 +/- 0.64, P<0.0001). Multivariable logistic regression analysis confirmed (1) sex, age, and lesion location in the right coronary artery as predictors for FFRp/iFRn discrepancy; and (2) hemoglobin level, smoking, and renal insufficiency as predictors for FFRn/iFRp discrepancy. The FFRn/iFRp type of discrepancy was significantly more frequent in patients with both risk types of polymorphisms (endothelial nitric oxide synthase(r)+heme oxygenase-1(r)): 8 patients (24.2%) compared with FFRp/iFRn type of discrepancy: 2 patients (5.9%), P=0.03. Conclusions:Predictors for FFRp/iFRn discrepancy were sex, age, and location in the right coronary artery. Predictors for FFRn/iFRp were hemoglobin level, smoking, and renal insufficiency. The risk type of polymorphism in endothelial nitric oxide synthase and heme oxygenase-1 genes was more frequently found in patients with FFRn/iFRp type of discrepancy.
Návaznosti
TN01000013, projekt VaV |
|